Blueprint Medicines (Acquisition)
Funding Details
- Awarder
- RSS - www.prnewswire.com
- Date Award
- June 02, 2025
- Vertical
- Pharmaceuticals
- Funding URL
- View Funding Page
Company Info
- Traction
- Blueprint Medicines has a strong pipeline of drug candidates and has made significant progress in clinical trials.
- Company Description
- Blueprint Medicines is focused on developing targeted therapies for patients with genomically defined cancers, rare diseases, and cancer immunotherapy.
- Market
- Immunology
- Location
- USA